Correlation Between Edgewise Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Hepion Pharmaceuticals
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Hepion is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.6 times more return on investment than Hepion Pharmaceuticals. However, Edgewise Therapeutics is 1.66 times less risky than Hepion Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 779.00 in Edgewise Therapeutics on August 30, 2024 and sell it today you would earn a total of 2,429 from holding Edgewise Therapeutics or generate 311.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Hepion Pharmaceuticals |
Edgewise Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Edgewise Therapeutics vs. Ikena Oncology | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. RenovoRx |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |